Zymeworks (ZYME) Change in Intangibles (2021 - 2025)
Zymeworks' (ZYME) quarterly Change in Intangibles came in at $139000.0 in Q4 2025, down 62.43% quarter-over-quarter from $370000.0 in Q2 2025.
Zymeworks (ZYME) Change in Intangibles (2021 - 2025) Analysis & Trends
Zymeworks has disclosed Change in Intangibles across 5 years of filings, most recently posting $139000.0 for Q4 2025.
- Change in Intangibles for Q4 2025 came in at $139000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $509000.0 (down 45.15% YoY), and the FY2025 annual result was $831000.0, down 22.7% from the prior year.
- Change in Intangibles came in at $139000.0 for Q4 2025 at Zymeworks, down from $370000.0 in the prior quarter.
- In the past five years, Change in Intangibles ranged from a high of $2.8 million in Q3 2022 to a low of $103000.0 in Q3 2024.
- The 5-year median for Change in Intangibles is $503000.0 (2024), against an average of $717307.7.
- Peak annual rise in Change in Intangibles reached 161.31% in 2023, while the deepest fall reached 92.71% in 2023.
- Zymeworks' Change in Intangibles stood at $841000.0 in 2021, then plunged by 36.39% to $535000.0 in 2022, then jumped by 161.31% to $1.4 million in 2023, then sank by 92.63% to $103000.0 in 2024, then jumped by 34.95% to $139000.0 in 2025.
- The last three Change in Intangibles figures came in at $139000.0 (Q4 2025), $370000.0 (Q2 2025), and $322000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.96 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 139,000.00 |
| Dec 31, 2025 | 139,000.00 |
| Jun 30, 2025 | 370,000.00 |
| Jun 30, 2025 | 370,000.00 |
| Mar 31, 2025 | 322,000.00 |
| Mar 31, 2025 | 322,000.00 |
| Sep 30, 2024 | 103,000.00 |
| Sep 30, 2024 | 103,000.00 |
| Jun 30, 2024 | 503,000.00 |
| Jun 30, 2024 | 503,000.00 |
| Mar 31, 2024 | 469,000.00 |
| Mar 31, 2024 | 469,000.00 |
| Dec 31, 2023 | 1.40 Mn |
| Dec 31, 2023 | 1.40 Mn |
| Sep 30, 2023 | 205,000.00 |
| Sep 30, 2023 | 205,000.00 |
| Dec 31, 2022 | 535,000.00 |
| Dec 31, 2022 | 535,000.00 |
| Sep 30, 2022 | 2.81 Mn |
| Sep 30, 2022 | 2.81 Mn |